Characteristic | Overall | ||||||
---|---|---|---|---|---|---|---|
Groups | Overall drug index | p value | Overall sex index | p value | Overall risk index | p value | |
Age | < 25 | .49 [.48–.50] | .89 | .71 [.70–.71] | .00 | .59 [.58–.59] | .00 |
> 26 | .49 [.48–.49] | .66 [.66–.67] | .57 [.56–.57] | ||||
Sex | Female | .50 [.48–.52] | .23 | .65 [.64–.67] | .01 | .57 [.56–.58] | .72 |
Male | .49 [.48–.49] | .67 [.67–.68] | .57 [.57–.57] | ||||
Overdose in the past 30 days | Yes | .53 [.51–.55] | .00 | .70 [.68–.72] | .00 | .61 [.59–.62] | .00 |
No | .49 [.48–.49] | .67 [.67–.67] | .57 [.56–.57] | ||||
Syringe use in the last 6 months | Always used a new syringe | .47 [.47–.48] | .00 | .67 [.66–.67] | .05 | .56 [.56–.56] | .00 |
Re-used syringes | .53 [.52–.54] | .68 [.67–.68] | .60 [.59–.60] | ||||
HIV knowledge | Yes | .49 [.49–.49] | .02 | .67 [.66–.67] | .19 | .57 [.57–.57] | .01 |
No | .48 [.46–.49] | .67 [.67–.67 | .56 [.55–.57] |